
Midlife brain remodeling: immune cell shifts and genome architecture decline
Researchers report a major midlife brain remodeling between about ages 50 and 75, including a sharp decline of embryonically derived microglia that are increasingly replaced by inflammatory, blood-derived cells, a weakening of cells maintaining the blood-brain barrier, and widespread deterioration of the genome's three-dimensional organization. The findings suggest aging involves coordinated remodeling across immune, vascular, and neuronal systems and may help explain why age is the strongest risk factor for Alzheimer’s and other neurodegenerative diseases, highlighting new potential therapeutic targets; the work is part of the NIH’s 4D Nucleome program and builds on single-cell analyses of the hippocampus.











